BRCA1-mutated simulations had a cumulative incidence of 45.9% (95% confidence interval 44.1–47.7%), a value that falls within the range of five previously published studies on breast cancer incidence in BRCA-1 mutation carriers (17–53%) [46–50]. This evidence concerns the gene BRCA1 and breast cancer.